Effective Jan. 1, 2022, all information concerning a prescription for controlled substances Schedule II — Schedule V, or information concerning a refill authorization for controlled substances Schedule III — Schedule V, must be communicated electronically unless one of the authorized exemptions are met, or the health care provider has obtained a waiver from the Department of Health (DOH).